Zentek has announced that it will embark on a Canada-wide sampling program for dental professionals facilitated by Henry Schein that will see ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers.
In addition to offering dental practitioners and their patients a surgical mask with improved protection against infectious agents, ZenGUARD™ Antimicrobial Surgical Masks are also said to be proven to eliminate 99.9% of bacteria, which can collect on the skin when wearing a surgical mask for extended periods and cause acne. The Company believes this program will introduce ZenGUARD™ Antimicrobial Surgical Masks and this unique value proposition to nearly all Henry Schein customers across Canada.
“The safety of staff and patients in dental practices is paramount, and surgical masks play a crucial role as they serve as a primary barrier against the transmission of infectious agents, including bacteria, viruses, and other pathogens. With the ability for ZenGUARD™ Antimicrobial Surgical Masks to eliminate bacteria and filter more virus particles compared to standard ASTM Level 3 surgical masks, we believe that this technology should be the new standard of protection for this incredibly important market segment,” said Greg Fenton, Zentek CEO.
Earlier this month, Zentek announced its intention to complete a non-brokered private placement of up to CAD$3 million (around USD$2,180,000).